Chemistry is an experimental science, Safety of H-D-Pro-OH, and the best way to enjoy it and learn about it is performing experiments.Introducing a new discovery about 344-25-2, Name is H-D-Pro-OH
With D-proline as the reducing and capping agent, fluorescent gold nanoclusters were rapidly prepared (D-Pro@AuNCs) within 10 min at 100 C. In the present of gold nanoparticles, the fluorescence of D-Pro@AuNCs was remarkably quenched. Interestingly, based on the electrostatic interaction between anticancer drug Raltitrexed and gold nanoparticles induced fluorescence ?turn-on? principle, a high selective assay for detection of Raltitrexed was established with the probe associating the fluorescence emission at 435 nm. The fluorescence intensity of D-Pro@AuNCs linearly correlated with the concentration of Raltitrexed in the range from 5.0 mumol/L to 40.0 mumol/L (R2 = 0.999) and the limit of detection was 1.9 mumol/L. Further, after Raltitrexed was abdominal injected in rats, a metabolic approach was constructed with the prepared fluorescent probe. It showed great potential of AuNCs-based sensing probes for application in analysis of serum anticancer drugs.
Sometimes chemists are able to propose two or more mechanisms that are consistent with the available data. Safety of H-D-Pro-OH, If a proposed mechanism predicts the wrong experimental rate law, however, the mechanism must be incorrect.Welcome to check out more blogs about 344-25-2, in my other articles.
Reference：
Metal catalyst and ligand design,
Ligand Template Strategies for Catalyst Encapsulation – NCBI